Faculty of 1000 evaluation for Ultraporous β-Tricalcium Phosphate Alone or Combined with Bone Marrow Aspirate for Benign Cavitary Lesions: Comparison in a Prospective Randomized Clinical Trial.

2013 ◽  
Author(s):  
Anskar Leung
Keyword(s):  
Clinical Trial ◽  
Bone Marrow ◽  
Randomized Clinical Trial ◽  
Tricalcium Phosphate ◽  
Bone Marrow Aspirate ◽  
Prospective Randomized Clinical Trial

scholarly journals COMPARISON BETWEEN CONCENTRATED BONE MARROW ASPIRATE AND CORTICOID IN GLUTEAL TENDINOPATHY

2021 ◽  
Vol 29 (1) ◽  
pp. 26-29
Author(s):  
DAVI ARAÚJO VEIGA ROSÁRIO ◽  
THIAGO BATISTA FALEIRO ◽  
BRUNO ADELMO FERREIRA MENDES FRANCO ◽  
GILDÁSIO DE CERQUEIRA DALTRO ◽  
REINALDO MARCHETTO
Keyword(s):  
Clinical Trial ◽  
Bone Marrow ◽  
Randomized Clinical Trial ◽  
Standard Treatment ◽  
Bone Marrow Aspirate ◽  
University Hospital ◽  
Level Of Evidence ◽  
Bone Marrow Aspirate Concentrate ◽  
Gluteal Tendinopathy ◽  
Significant Difference

ABSTRACT Objective: To compare bone marrow aspirate concentrate (BMAC) with the standard treatment for gluteal tendinopathies. Methods: 48 patients diagnosed with gluteal tendinopathy at a university hospital were selected by a randomized clinical trial and divided into two groups: (G1) bone marrow aspirate concentrate and (G2) corticosteroid injections. Results: 40 of the 48 selected patients were monitored for six months and both groups showed better scores. Visual analog scale (VAS) scores and Lequesne index were statistically significant higher in patients submitted to BMAC treatment when compared to standard treatment. Both groups improved their quality of life, without statistically significant difference. Conclusion: BMAC constitutes an alternative to gluteal tendinopathy standard treatment, proving to be a safe technique with promising results when combined with multidisciplinary team behavioral therapy. Level of Evidence II, Randomized Clinical Trial.

Sign in / Sign up

Export Citation Format

Share Document